The Lancet has recently published an update to the progression-free survival (PFS) data of theICON6 trial. (The preliminary data was first presented at the European Society of Medical Oncology congress in … Continued
(March 31, 2016) The Lancet has recently published an update to the progression-free survival (PFS) data of the ICON6 trial. (The preliminary data was first presented at the European Society of … Continued
(March 30, 2016) OCRFA staff and volunteers recently attended the Society of Gynecologic Oncology’s (SGO) Annual Meeting on Women’s Cancer, held March 19-22, 2016 in San Diego. Every year women’s … Continued
By: Annie Ellis, Ovarian Cancer Survivor and Research Advocate Women’s cancer specialists from all over the world convened in San Diego in March to hear about the latest developments in women’s … Continued
OCRFA staff and volunteers recently attended the Society of Gynecologic Oncology’s (SGO) Annual Meeting on Women’s Cancer, held March 19-22, 2016 in San Diego. Every year women’s cancer physicians and … Continued
Ovarian Cancer Research Alliance today announced the online publication of a collaborative best practices paper entitled, “Understanding Hereditary Cancer in the Era of Multi-Gene Panel Testing.” The paper offers key … Continued
(March 22, 2016) A new article in Gynecologic Oncology describes clinical features—some surprising—found in women surviving high-grade serous carcinoma for ten or more years. OCRF Scientific Advisory Committee member and … Continued
Q&A with Jill Madden, PhD University of Kansas Medical Center Research Institute, Inc. 2016 Ann Schreiber Mentored Investigator Award OCRFA: Tell me about yourself. Did you always want to … Continued
The Institute of Medicine (IOM) recently released a report commissioned by Congress, Ovarian Cancers: Evolving Paradigms in Research and Care. The report provides an in-depth look at the state of … Continued
(March 3, 2016) In a study published in the New England Journal of Medicine this week, researchers report that a dose-dense weekly paclitaxel regimen failed to improve progression-free survival in advanced … Continued
The Minnesota Ovarian Cancer Alliance (MOCA) formed in 1999, when a small group of survivors, united by their doctors, gathered around a dining room table. They realized the lack of … Continued
Rockin 4A Cause was founded by 4 couples who had each lost someone very close to them to three different diseases, including most recently Dyan Elovich Blumberg to ovarian cancer. … Continued
Get email updates about research news, action alerts, and ways to join the fight.
